On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

RFX5

regulatory factor X5

The RFX5 gene provides instructions for a protein that plays a critical role in the regulation of genes involved in the body's immune response. RFX5 encodes the regulatory factor X5 protein, which is part of a complex that controls the activity of major histocompatibility complex (MHC) class II genes.

Chromosome 1q21.3 HGNC:9986 Tier C
RFX5 1q21.3 p arm q arm 1

RFX5 is located on the long (q) arm of chromosome 1, at band 1q21.3. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 1 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The RFX5 gene, also known as regulatory factor X5, is fundamental for proper immune system function. It provides the genetic blueprint for a protein that is part of a larger complex, responsible for regulating the expression of specific genes.

This regulation is crucial for the production of major histocompatibility complex (MHC) class II proteins, which are key components of the immune system's ability to identify and respond to pathogens.

What the gene does

The RFX5 protein is a component of the regulatory factor X (RFX) complex, a group of proteins that primarily regulates the transcription of major histocompatibility complex (MHC) class II genes. Transcription is the process by which genetic information from DNA is copied into RNA, serving as the first step in protein production. The RFX complex attaches to specific DNA regions, and RFX5 helps guide this attachment, enabling the activation of MHC class II gene transcription.

MHC class II proteins are found on the surface of various immune cells, including lymphocytes. They play a vital role in the immune system's response to foreign invaders by binding to pathogen-derived protein fragments. This presentation allows other specialised immune cells to recognise these fragments as harmful, triggering an immune response to eliminate the invaders.

While its primary role is in MHC class II gene regulation, the RFX complex, including RFX5, also contributes to the transcription of MHC class I genes. These genes also produce immune system proteins that present foreign peptides to immune cells, although other proteins are the main regulators for MHC class I activity.

Video: Genetics 101

Chromosome location

The RFX5 gene is located on chromosome 1, specifically at position 1q21.3. This genomic address specifies its precise place within the human genome.

Protein structure

The RFX5 protein consists of 616 amino acids. Its structure includes a Disordered region at amino acids 1-29 and an N-terminal domain from amino acids 25-90. A Leucine-rich region, located at amino acids 62-66, is crucial for dimer formation and interaction with RFXAP. The protein features an RFX-type winged-helix domain (amino acids 92-168) which is involved in DNA binding. Additionally, a PxLPxI/L motif (amino acids 173-178) mediates interaction with RFXANK. Further Disordered regions are present at amino acids 252-314 and 391-616.

Domain map · 616 amino acids
N-terminal domain (25-90)Leucine-rich region; critical for dimer formation and for interaction with RFXAP (62-66)RFX-type winged-helix (92-168)PxLPxI/L motif; mediates interaction with RFXANK (173-178)N-terminal domain25-90RFX-type winged-helix92-168PxLPxI/L motif; mediat173-1781~308616
Region - functional region
Region - functional region
Motif - short conserved sequence
🧬 Explore 3D structure on AlphaFold
UniProt:P48382Length:616 aaStructure:AlphaFold

Key variants

Genetic variations, or variants, in the RFX5 gene can impact its ability to produce a functional protein, potentially affecting immune system regulation. These variants can lead to a range of effects, depending on their specific nature and location within the gene.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for RFX5.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.103C>T
single nucleotide variant
p.Arg35Ter Pathogenic/Likely pathogenic ★★☆☆ RFX5-related disorder
c.1578_1594dup
Duplication
p.Gln532fs Pathogenic/Likely pathogenic ★★☆☆ MHC class II deficiency
c.386del
Deletion
p.Pro129fs Pathogenic/Likely pathogenic ★★☆☆ MHC class II deficiency
c.56dup
Duplication
p.Gly20fs Pathogenic/Likely pathogenic ★★☆☆ MHC class II deficiency
c.715C>T
single nucleotide variant
p.Arg239Ter Pathogenic ★★☆☆ MHC class II deficiency
c.757+1G>A
single nucleotide variant
- Pathogenic/Likely pathogenic ★★☆☆ MHC class II deficiency
c.880C>T
single nucleotide variant
p.Arg294Ter Pathogenic/Likely pathogenic ★★☆☆ MHC class II deficiency 3
c.1198C>T
single nucleotide variant
p.Arg400Ter Pathogenic ★☆☆☆ MHC class II deficiency 1
c.1414_1415del
Deletion
p.Lys472fs Pathogenic ★☆☆☆ MHC class II deficiency
c.198dup
Duplication
p.Gln67fs Pathogenic ★☆☆☆ MHC class II deficiency

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variations within the RFX5 gene are known to be associated with specific health conditions, predominantly affecting the immune system. These conditions can arise when the RFX5 protein's function is impaired, leading to deficiencies in immune response.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

The RFX5 gene is included in several NHS England Genomic Medicine Service national test directories, indicating its clinical relevance within the UK. It is categorised as 'green' for both "COVID-19 research" and "Primary immunodeficiency or monogenic inflammatory bowel disease (R15)" panels on PanelApp, meaning there is sufficient evidence for its routine use in diagnostic testing for these conditions.

Frequently asked questions

What is the primary role of the RFX5 gene?

The RFX5 gene provides instructions for a protein that helps regulate the activity of major histocompatibility complex (MHC) class II genes, which are essential for immune system function and recognising foreign invaders.

What are MHC class II proteins?

MHC class II proteins are specialised immune proteins found on the surface of certain immune cells. They bind to fragments of foreign proteins, presenting them to other immune cells to initiate an immune response against pathogens.

How does the RFX5 protein contribute to immunity?

The RFX5 protein is part of a complex that ensures the correct activation of MHC class II genes. This activation leads to the production of MHC class II proteins, which are vital for the immune system to effectively identify and respond to threats like bacteria and viruses.

References

  1. Garvie CW, Boss JM. Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5. Biochimica et biophysica acta. 2008. PMID: 18723135
  2. Burd AL, Ingraham RH, Goldrick SE. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins. Biochemistry. 2004. PMID: 15461447
  3. Gobin SJ, Peijnenburg A, van Eggermond M. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity. 1998. PMID: 9806639
  4. Villard J, Reith W, Barras E. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Human mutation. 1997. PMID: 9401005
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .